McIntyreRS, KonarskiJZ, WilkinsK, et al.Obesity in bipolar disorder and major depressive disorder: Results from a national community health survey on mental health and well-being. Can J Psychiatry, 2006; 51:274–280.
2.
StrassnigM, KotovR, CornaccioD, et al.Twenty-year progression of body mass index in a county wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis. Bipolar Disord, 2017; 19:336–343.
3.
FagioliniA, KupferDJ, HouckPR, et al.Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry, 2003; 160:112–117.
4.
SimonGE, Von KorffM, SaundersK, et al.Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry, 2006; 63:824–830.
5.
LassaleC, BattyGD, BaghdadliA, et al.Healthy dietary indices and risk of depressive outcomes: A systematic review and meta-analysis of observational studies. Mol Psychiatry, 2019; 24:965–986.
6.
ChenVC-H, LiuY-C, ChaoS-H, et al.Brain structural networks and connectomes: The brain-obesity interface and its impact on mental health. Neuropsychiatr Dis Treat, 2018; 14:3199–3208.
7.
RajkumarAP, HorsdalHT, WimberleyT, et al.Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: A Danish population-based cohort study. Am J Psychiatry, 2017; 174:686–694.
8.
KanC, PedersenNL, ChristensenK, et al.Genetic overlap between type 2 diabetes and depression in Swedish and Danish twin registries. Mol Psychiatry, 2016; 21:903–909.
9.
PillingerT, BeckK, GobjilaC, et al.Impaired glucose homeostasis in first-episode schizophrenia. JAMA Psychiatry, 2017; 74:261–269.
10.
KuangH, DuongA, JeongH, et al.Lactate in bipolar disorder: A systematic review and meta‐analysis. Psychiatry Clin Neurosci, 2018; 72:546–555.
11.
KetterTA, KimbrellTA, GeorgeMS, et al.Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry, 2001; 49:97–109.
12.
SunL, GetzM, DaboulS, et al.Independence of diabetes and obesity in adults with serious mental illness: Findings from a large Urban Public Hospital. J Psychiatr Res, 2018; 99:159–166.
13.
FanZ, WuY, ShenJ, et al.Schizophrenia and the risk of cardiovascular diseases: A meta-analysis of thirteen cohort studies. J Psychiatr Res, 2013; 47:1549–1556.
14.
LettHS, BlumenthalJA, BabyakMA, et al.Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment. Psychosom Med, 2004; 66:305–315.
15.
Plana-RipollO, PedersenCB, AgerboE, et al.A comprehensive analysis of mortality-related health metrics associated with mental disorders: A nationwide, register-based cohort study. Lancet, 2019; 394:1827–1835.
16.
DananA, WestmanEC, SaslowLR, EdeG. The ketogenic diet for refractory mental illness: A retrospective analysis of 31 inpatients. Front Psychiatry, 2022; 13:951376.
17.
JantaratnotaiN, MosikanonK, LeeY, McIntyreRS. The interface of depression and obesity. Obes Res Clin Pract, 2017; 11:1–10.
18.
MurphyP, LikhodiiS, NylenK, BurnhamWM. The antidepressant properties of the ketogenic diet. Biol Psychiatry, 2004; 56:981–983.
19.
YancyYS, AlmirallD, MaciejewskiML, et al.Effects of two weight-loss diets on health-related quality of life. Qual Life Res, 2009; 18:281–289.
20.
WiersCE, VendruscoloLF, van der VeenJW, et al.Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents. Sci Adv, 2021; 7:eabf6780.
